206 related articles for article (PubMed ID: 20615241)
21. Quantitative and Dynamic Imaging of ATM Kinase Activity by Bioluminescence Imaging.
Nyati S; Young G; Ross BD; Rehemtulla A
Methods Mol Biol; 2017; 1599():97-111. PubMed ID: 28477114
[TBL] [Abstract][Full Text] [Related]
22. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
23. Computational Approaches Towards Kinases as Attractive Targets for Anticancer Drug Discovery and Development.
Hameed R; Khan A; Khan S; Perveen S
Anticancer Agents Med Chem; 2019; 19(5):592-598. PubMed ID: 30306880
[TBL] [Abstract][Full Text] [Related]
24. Targeting cancer with small-molecular-weight kinase inhibitors.
Fabbro D; Cowan-Jacob SW; Möbitz H; Martiny-Baron G
Methods Mol Biol; 2012; 795():1-34. PubMed ID: 21960212
[TBL] [Abstract][Full Text] [Related]
25. Firefly luciferase enzyme fragment complementation for imaging in cells and living animals.
Paulmurugan R; Gambhir SS
Anal Chem; 2005 Mar; 77(5):1295-302. PubMed ID: 15732910
[TBL] [Abstract][Full Text] [Related]
26. Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery.
Bellinger AM; Arteaga CL; Force T; Humphreys BD; Demetri GD; Druker BJ; Moslehi JJ
Circulation; 2015 Dec; 132(23):2248-58. PubMed ID: 26644247
[TBL] [Abstract][Full Text] [Related]
27. Cell lysis-free quantum dot multicolor cellular imaging-based mechanism study for TNF-α-induced insulin resistance.
Kim MJ; Rangasamy S; Shim Y; Song JM
J Nanobiotechnology; 2015 Jan; 13():4. PubMed ID: 25623542
[TBL] [Abstract][Full Text] [Related]
28. Introducing a new reporter gene, membrane-anchored
Moroz MA; Zurita J; Moroz A; Nikolov E; Likar Y; Dobrenkov K; Lee J; Shenker L; Blasberg R; Serganova I; Ponomarev V
Mol Ther Oncolytics; 2021 Jun; 21():15-22. PubMed ID: 33851009
[TBL] [Abstract][Full Text] [Related]
29. Live visualization and quantification of pathway signaling with dual fluorescent and bioluminescent reporters.
Afshari A; Uhde-Stone C; Lu B
Biochem Biophys Res Commun; 2014 Jun; 448(3):281-6. PubMed ID: 24792187
[TBL] [Abstract][Full Text] [Related]
30. Different Types of Luciferase Reporters Show Distinct Susceptibility to T3-Evoked Downregulation.
Kollár A; Kvárta-Papp Z; Egri P; Gereben B
Thyroid; 2016 Jan; 26(1):179-82. PubMed ID: 26629840
[TBL] [Abstract][Full Text] [Related]
31. Development and Validation of a Novel Dual Luciferase Reporter Gene Assay to Quantify Ebola Virus VP24 Inhibition of IFN Signaling.
Fanunza E; Frau A; Sgarbanti M; Orsatti R; Corona A; Tramontano E
Viruses; 2018 Feb; 10(2):. PubMed ID: 29495311
[TBL] [Abstract][Full Text] [Related]
32. A molecular imaging biosensor detects in vivo protein folding and misfolding.
Sheahan AV; Sekar TV; Chen K; Paulmurugan R; Massoud TF
J Mol Med (Berl); 2016 Jul; 94(7):799-808. PubMed ID: 27277823
[TBL] [Abstract][Full Text] [Related]
33. Quantification of dynamic protein complexes using Renilla luciferase fragment complementation applied to protein kinase A activities in vivo.
Stefan E; Aquin S; Berger N; Landry CR; Nyfeler B; Bouvier M; Michnick SW
Proc Natl Acad Sci U S A; 2007 Oct; 104(43):16916-21. PubMed ID: 17942691
[TBL] [Abstract][Full Text] [Related]
34. AAV-based dual-reporter circuit for monitoring cell signaling in living human cells.
Zhang Z; Stickney Z; Duong N; Curley K; Lu B
J Biol Eng; 2017; 11():18. PubMed ID: 28592991
[TBL] [Abstract][Full Text] [Related]
35. Integrated technology platform protein kinases for drug development in oncology.
Sachsenmaier C; Schächtele C
Biotechniques; 2002 Oct; Suppl():101-6. PubMed ID: 12395934
[TBL] [Abstract][Full Text] [Related]
36. Involvement of MAP kinase in insulin signalling revealed by non-invasive imaging of luciferase gene expression in single living cells.
Rutter GA; White MR; Tavaré JM
Curr Biol; 1995 Aug; 5(8):890-9. PubMed ID: 7583147
[TBL] [Abstract][Full Text] [Related]
37. Systematic Quantification of GPCR/cAMP-Controlled Protein Kinase A Interactions.
Torres-Quesada O; Röck R; Stefan E
Horm Metab Res; 2017 Apr; 49(4):240-249. PubMed ID: 28427097
[TBL] [Abstract][Full Text] [Related]
38. A dual Ucp1 reporter mouse model for imaging and quantitation of brown and brite fat recruitment.
Wang H; Willershäuser M; Karlas A; Gorpas D; Reber J; Ntziachristos V; Maurer S; Fromme T; Li Y; Klingenspor M
Mol Metab; 2019 Feb; 20():14-27. PubMed ID: 30580967
[TBL] [Abstract][Full Text] [Related]
39. Imaging chemokine receptor dimerization with firefly luciferase complementation.
Luker KE; Gupta M; Luker GD
FASEB J; 2009 Mar; 23(3):823-34. PubMed ID: 19001056
[TBL] [Abstract][Full Text] [Related]
40. CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma.
Wang L; Su W; Liu Z; Zhou M; Chen S; Chen Y; Lu D; Liu Y; Fan Y; Zheng Y; Han Z; Kong D; Wu JC; Xiang R; Li Z
Biomaterials; 2012 Jul; 33(20):5107-14. PubMed ID: 22494888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
